Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01012297
Brief Title: Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

First Submitted : November 12, 2009
First Submitted that Met QC Criteria : November 12, 2009
First Posted : November 13, 2009 (Estimate)

Results First Submitted : January 26, 2017
Results First Submitted that Met QC Criteria : July 13, 2017
Results First Posted : July 14, 2017

Last Update Submitted that Met QC Criteria : August 20, 2020
Last Update Posted : September 2, 2020